Literature DB >> 19601800

p53-Induced apoptosis and inhibitors of p53.

Surendra Kumar Nayak1, Paramjit Singh Panesar, Harish Kumar.   

Abstract

Protein p53 is a key player in mitochondrial mediated apoptotic cell death and excess p53 activity has been implicated in many disease states such athrosclerosis, diabetes, osteoarthritis, Alzheimer's disease, Parkinson's disease, Huntington's disease, AIDS, P. falciparum and S. typhimurium infections. Thus, chemical inhibitors of p53 activation might prove effective in suppressing diseases associated with excess p53 activity. Diverse chemical compounds are being synthesized and evaluated as potent inhibitors of p53 in many cell types. In this review, we have focused on the effects of apoptosis, which is involved in p53 protein and inhibition of p53 induced apoptosis. Peculiar features of p53 protein and its roles in various diseases are summarized along with important inhibitors developed in recent years.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19601800     DOI: 10.2174/092986709788681976

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  8 in total

1.  Rational design of cyclic peptide modulators of the transcriptional coactivator CBP: a new class of p53 inhibitors.

Authors:  Guillermo Gerona-Navarro; Shiraz Mujtaba; Antonio Frasca; Jigneshkumar Patel; Lei Zeng; Alexander N Plotnikov; Roman Osman; Ming-Ming Zhou
Journal:  J Am Chem Soc       Date:  2011-01-27       Impact factor: 15.419

2.  The up-regulation of histone deacetylase 8 promotes proliferation and inhibits apoptosis in hepatocellular carcinoma.

Authors:  Jian Wu; Chengli Du; Zhen Lv; Chaofeng Ding; Jun Cheng; Haiyang Xie; Lin Zhou; Shusen Zheng
Journal:  Dig Dis Sci       Date:  2013-12       Impact factor: 3.199

3.  Cognitive impairments accompanying rodent mild traumatic brain injury involve p53-dependent neuronal cell death and are ameliorated by the tetrahydrobenzothiazole PFT-α.

Authors:  Lital Rachmany; David Tweedie; Vardit Rubovitch; Qian-Sheng Yu; Yazhou Li; Jia-Yi Wang; Chaim G Pick; Nigel H Greig
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

4.  Effect of Trp53 gene deficiency on brain injury after neonatal hypoxia-ischemia.

Authors:  Ana A Baburamani; Kristina S Sobotka; Regina Vontell; Carina Mallard; Veena G Supramaniam; Claire Thornton; Henrik Hagberg
Journal:  Oncotarget       Date:  2017-02-14

5.  Overexpression of DJ-1 alleviates autosomal dominant polycystic kidney disease by regulating cell proliferation, apoptosis, and mitochondrial metabolism in vitro and in vivo.

Authors:  Zhongxin Li; Jingjing Zhou; Yan Li; Fan Yang; Xiaoying Lian; Wenhu Liu
Journal:  Ann Transl Med       Date:  2020-09

6.  Identification of a small molecule 1,4-bis-[4-(3-phenoxy-propoxy)-but-2-ynyl]-piperazine as a novel inhibitor of the transcription factor p53.

Authors:  Xin Liu; Ying Zhang; Man Tong; Xiu-ying Liu; Guan-zheng Luo; Dong-fang Xie; Shao-fang Ren; Dong-hui Bai; Liu Wang; Qi Zhou; Xiu-jie Wang
Journal:  Acta Pharmacol Sin       Date:  2013-06       Impact factor: 6.150

Review 7.  Regulating tumor suppressor genes: post-translational modifications.

Authors:  Ling Chen; Shuang Liu; Yongguang Tao
Journal:  Signal Transduct Target Ther       Date:  2020-06-10

8.  Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.

Authors:  Duncan A Hay; Oleg Fedorov; Sarah Martin; Dean C Singleton; Cynthia Tallant; Christopher Wells; Sarah Picaud; Martin Philpott; Octovia P Monteiro; Catherine M Rogers; Stuart J Conway; Timothy P C Rooney; Anthony Tumber; Clarence Yapp; Panagis Filippakopoulos; Mark E Bunnage; Susanne Müller; Stefan Knapp; Christopher J Schofield; Paul E Brennan
Journal:  J Am Chem Soc       Date:  2014-06-19       Impact factor: 15.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.